RADHAKISHAN PHARMACEUTICALS
ERLOCIP ERLOTINIB TABLETS IP

ERLOCIP ERLOTINIB TABLETS IP

ERLOCIP ERLOTINIB TABLETS IP Specification

  • Indication
  • Non-Small Cell Lung Cancer, Pancreatic Cancer
  • Salt Composition
  • Erlotinib Hydrochloride (equivalent to Erlotinib) 150 mg
  • Dosage Form
  • Film-coated Tablet
  • Feature
  • Oral Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor
  • Ingredients
  • Erlotinib Hydrochloride, Excipients
  • Application
  • Anticancer Therapy
  • Physical Color/Texture
  • White to off-white, round, film-coated tablets
  • Fermentation Smell
  • Odorless
  • Storage Instructions
  • Store below 30C, protect from light and moisture
  • Shelf Life
  • 24 months
  • Packaging Size
  • 30 Tablets per bottle
  • Brand Name
  • ERLOCIP
  • Usage
  • As directed by oncologist
  • Storage Conditions
  • Keep in original package
  • Box Contents
  • One bottle containing 30 tablets, package insert
  • ATC Code
  • L01XE03
  • Prescription Status
  • Prescription only (Rx)
  • Administration Route
  • Oral
  • Strength
  • 150 mg
 

ERLOCIP ERLOTINIB TABLETS IP Trade Information

  • Packaging Details
  • Pack of 30 tablets - Erlocip
  • Main Domestic Market
  • All India
  • Certifications
  • Composition:Erlotinib hydrochloride Manufactured By:Cipla Usage:Hospital No of tablets:30 Brand:Erlocip Form of Medicine:Tablets Dose:150mg Dose/Strength:100mg/ 150mg
 

About ERLOCIP ERLOTINIB TABLETS IP

Erlocip 150Mg Erlotinib

ERLOCIP 150 MG TABLETS - ERLOTINIB HYDROCHLORIDE

Erlocip Tablets Contains Erlotinib And Its Available As : 100 Mg & 150 Mg Tablets.

Specification :-

  • Composition:Erlotinib hydrochloride
  • Manufactured By:Cipla
  • Usage:Hospital
  • No of tablets:30
  • Brand:Erlocip
  • Form of Medicine:Tablets
  • Dose:150mg
  • Dose/Strength:100mg/ 150mg

Note: Erlocip Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug...............



Targeted Anticancer Solution

ERLOCIP Erlotinib Tablets deliver targeted therapy for patients with non-small cell lung cancer and pancreatic cancer. By inhibiting the EGFR tyrosine kinase, these tablets help slow or stop the proliferation of cancer cells. Their oral administration makes them convenient for long-term cancer management under an oncologists guidance.


Simple Oral Administration

Designed for ease of use, ERLOCIP tablets are taken orally as prescribed by a healthcare specialist. Their film-coated formulation ensures smooth ingestion and precise dosing. Always follow your oncologists instructions regarding timing and dosage for optimal therapeutic effects and safety.


Safe Storage and Handling

ERLOCIP should always be kept in its original bottle, tightly closed, away from light and moisture, and stored below 30C. Proper storage protects the medications integrity during its 24-month shelf life. For any unused or expired medicine, follow your pharmacists or oncologists directions for safe disposal.

FAQs of ERLOCIP ERLOTINIB TABLETS IP:


Q: How should ERLOCIP Erlotinib 150 mg tablets be taken?

A: ERLOCIP should be taken orally exactly as prescribed by your oncologist, usually once daily, with or without food. Do not adjust your dosage without professional guidance.

Q: What is ERLOCIP 150 mg used for?

A: This medication is indicated for the treatment of non-small cell lung cancer and pancreatic cancer, specifically in patients whose cancer involves the epidermal growth factor receptor (EGFR) pathway.

Q: When should I take ERLOCIP tablets?

A: Its recommended to take ERLOCIP at the same time every day for best results. Always adhere to the schedule provided by your healthcare professional.

Q: Where should ERLOCIP be stored?

A: Store ERLOCIP tablets in their original packaging at temperatures below 30C, protected from light and moisture. Avoid removing the tablets from the bottle until ready to use each dose.

Q: What benefits does ERLOCIP offer in cancer therapy?

A: ERLOCIP targets the EGFR tyrosine kinase, potentially slowing cancer cell growth and improving outcomes for eligible patients with non-small cell lung or pancreatic cancer.

Q: What should I do if I miss a dose of ERLOCIP?

A: If you miss a dose, take it as soon as you remember unless its almost time for your next dose. Never take two doses at once, and consult your doctor for further instructions.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anticancer Medicines Category

Molnuvid Molnupiravir Capsules

Molnuvid Molnupiravir Capsules

Minimum Order Quantity : 1 Piece

Application : Other, Antiviral medication

Shelf Life : 24 months

Ingredients : Other , Molnupiravir 200 mg, Excipients Q.S.

Dosage Form : Capsule

Feature : Other, Oral antiviral, easy administration, for emergency use

BARINAT-BARICITINIB TABLETS

BARINAT-BARICITINIB TABLETS

Minimum Order Quantity : 1 Bottle

Application : Other

Shelf Life : 24 to 36 months

Ingredients : Other

Dosage Form : Tablet

Feature : Other

Iverheal Ivermectin 12 Mg Tablets

Iverheal Ivermectin 12 Mg Tablets

Minimum Order Quantity : 1 Piece

Application : Other, Oral administration

Shelf Life : 24 months

Ingredients : Other , Ivermectin and excipients

Dosage Form : Tablet

Feature : Other, Antiparasitic, broadspectrum activity

VEENAT 100 MG  IMATINIB CAPSULES

VEENAT 100 MG IMATINIB CAPSULES

Application : Other, Cancer therapy, specifically for CML and GIST

Shelf Life : 24 Months

Ingredients : Other , Imatinib Mesylate, Excipients Q.S.

Dosage Form : Capsules

Feature : Other, Oral, targeted therapy, prescription only



Back to top